Bristol-Myers Squibb (BMY)
$39.78
0.12 (0.31%)
BMY Stock Quote Delayed 30 Minutes
7 Stocks to Buy in July
With Independence Day gone, traders should look to historically strong stocks during July, such as consumer staples, utilities and healthcare stocks.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
88.40B
PE Ratio
-12.83
EPS
-3.1
Volume (Avg. Vol.)
3.32M
Day's Range
$39.50 - $39.94
52-Week Range
$39.35 - $65.38
Dividend & Yield
$2.28 (5.73%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)
Bristol-Myers Squibb (BMY), Pfizer (PFE) and Amgen (AMGN) are teasing the technical traders as their charts suggest the potential for a short-term buying opportunity.
Catch Bristol-Myers Squibb Co (BMY) Stock With Confidence
Catching a pharma falling knife is dangerous work, but if you're careful in Bristol-Myers Squibb, you can make money with BMY stock.
Vanguard Sector Funds
These four low-cost Vanguard sector funds can be smart choices to strengthen your portfolio with tactical exposure.
42 Stocks On a Slippery Slope
I've updated my Portfolio Grader rankings, and investors may want to avoid this list of stocks for now
Buy Bristol-Myers Squibb Co (BMY) Stock Without Fear
The consensus is that Trump will destroy the Biotech industry. I bet this will pass with little change, so go long BMY with room for error.
Carl Icahn’s Stake in Bristol-Myers Squibb Co (BMY) Fuels Takeover Talk
Bristol-Myers Squibb Co (BMY) may be the next target for a takeover by Carl Icahn now that he's taken a large stake in the company.
3 Big Stock Charts for Thursday: Bristol-Myers Squibb Co. (BMY), Cincinnati Financial Corporation (CINF) and Hasbro, Inc. (HAS)
Shares of Cincinnati Financial (CINF), Bristol-Myers Squibb (BMY) and Hasbro (HAS) are all hitting overbought readings.
Thursday’s Vital Data: Apple Inc. (AAPL), Groupon Inc (GRPN) and Bristol-Myers Squibb Co (BMY)
Apple (AAPL) is the No. 1 smartphone seller in Q4, Bristol-Myers Squibb (BMY) options spike on buyout rumors and Groupon (GRPN) soars on strong earnings.
3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Visa Inc (V) and Fiserv Inc (FISV)
Bristol-Myers (BMY) have rallied from a deeply oversold chart reading, while Visa's (V) rally looks tempting and Fiserv (FISV) shares are sitting in a technical squeeze play.
Why Rite Aid Corporation (RAD), General Electric Company (GE) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks
Rite Aid (RAD), Bristol-Myers Squibb (BMY) and General Electric (GE) ended the trading week on a bearish foot.
Why Merck & Co., Inc. (MRK) Stock Is Higher Today
Merck & Co., Inc. (MRK) stock surged 3.6% Friday as the company is a step ahed of competitor Bristol-Myers in its lung cancer drug research.
Go Long Bristol-Myers Squibb Co (BMY) Stock for Panic Profits!
Pharmaceutical stocks like Bristol-Myers Squibb (BMY) have been toxic for months, but BMY stock is about to turn lemons into lemonade.
Why Juniper Networks, Inc. (JNPR), Supervalu Inc. (SVU) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks
Juniper Networks (JNPR), Bristol-Myers Squibb (BMY) and Supervalu (SVU) lost their uphill battles they were forced to fight on Wednesday.
Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”
Pfizer (PFE) and Lockheed Martin (LMT) were among the stocks that were rattled Wednesday during Donald Trump's press conference.
Merck & Co., Inc. (MRK) Stock Is Defying the Bears!
Merck & Co. (MRK) has gifted traders with an early 2017 trading signal. Thanks to Tuesday's bounce, MRK stock could enjoy new buying pressure.
BMY Stock: Don’t Try to Catch This Falling Knife … Yet
Bristol-Myers (BMY) stock is a hot mess right now, but it still has long-term value in its cancer drug pipeline.
